P&G Health - Procter & Gamble Health Share Price

6,244.00-66.50 (-1.06%)

Closed
As On: 19 Jun, 2026, 03:40 PM IST
As On: 19 Jun, 2026, 03:40 PM IST

Sector: Pharmaceuticals
Industry: Pharma - MNC

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	6,293.00
High	6,380.00
Low	6,212.00
Prev Close	6,310.50
Volume	12,057
VWAP(₹)	6,269.41

Share Price	Value
Today/Current/Last	6,244.006,309.55
Previous Day	6,310.506,316.90

P&G Health Share Recommendations

Mean recosCurrent

BUY

1 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	-	-	-	-
Buy	1	1	-	-
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	-	-

Recent Recos

Target₹5620
OrganizationICICI Direct
BUY

Target₹5315
OrganizationICICI Direct
BUY

Target₹7300
OrganizationIIFL
BUY

View all Stock Recommendations

News & Analysis

View all P&G Health Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	378.22	378.22	329.87	342.77	314.10
Total Income Growth (%)	14.66	0.00	-3.76	9.13	0.12
Total Expenses	269.30	269.30	210.73	253.84	235.44
Total Expenses Growth (%)	27.79	0.00	-16.98	7.82	22.70
EBIT	108.92	108.92	119.14	88.93	78.66
EBIT Growth (%)	-8.58	0.00	33.97	13.06	-35.44
Profit after Tax (PAT)	77.59	77.59	88.54	66.18	61.18
PAT Growth (%)	-12.37	0.00	33.79	8.17	-32.70
EBIT Margin (%)	28.80	28.80	36.12	25.94	25.04
Net Profit Margin (%)	20.51	20.51	26.84	19.31	19.48
Basic EPS (₹)	46.74	46.74	53.34	39.87	36.86

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	944.52	1,166.89	1,248.01	1,127.60	1,026.83
Total Revenue Growth (%)	-19.06	-6.50	10.68	9.81	-27.93
Total Expenses	632.90	873.38	933.81	874.23	793.55
Total Expenses Growth (%)	-27.53	-6.47	6.82	10.17	-25.83
Profit after Tax (PAT)	234.41	200.98	229.47	192.52	176.80
PAT Growth (%)	16.63	-12.42	19.19	8.89	-30.42
Operating Profit Margin (%)	33.40	25.55	25.61	22.77	23.20
Net Profit Margin (%)	25.09	17.45	18.66	17.27	17.52
Basic EPS (₹)	141.00	133.00	138.00	116.00	107.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 50.9% outperformed its 3 year CAGR of 4.48%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 15.81% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	794.20	794.36	1,101.19	893.72	986.16
Total Assets Growth (%)	-0.02	-27.86	23.21	-9.37	-16.12
Total Liabilities	257.24	256.12	350.30	277.23	282.45
Total Liabilities Growth (%)	0.44	-26.89	26.36	-1.85	4.84
Total Equity	536.96	538.24	750.89	616.49	703.71
Total Equity Growth (%)	-0.24	-28.32	21.80	-12.39	-22.36
Current Ratio (x)	2.44	2.39	2.62	2.60	3.04
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	187.34	165.89	165.48	258.16	244.23

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	168.69	228.29	236.00	169.52	247.26
Net Cash used in Investing Activities	9.59	-6.87	-21.50	-25.54	-32.27
Net Cash flow from Financing Activities	-234.74	-418.11	-98.48	-288.63	-386.63
Net Cash Flow	-56.46	-196.69	116.02	-144.65	-171.64
Closing Cash & Cash Equivalent	182.27	238.73	435.42	319.40	464.05
Closing Cash & Cash Equivalent Growth (%)	-23.65	-45.17	36.32	-31.17	-27.00
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	43.65	37.34	30.55	31.22	25.12
Return on Capital Employed (%)	53.90	51.13	39.50	38.57	31.32
Return on Assets (%)	29.51	25.30	20.83	21.54	17.92
Interest Coverage Ratio (x)	764.51	446.71	445.55	668.74	292.60
Asset Turnover Ratio (x)	1.18	1.21	1.23	1.19	102.28
Price to Earnings (x)	36.50	41.84	38.02	36.23	52.63
Price to Book (x)	15.90	15.57	11.60	11.28	13.20
EV/EBITDA (x)	25.39	25.30	24.12	23.59	33.38
EBITDA Margin (%)	35.19	27.93	27.90	25.20	26.18

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 62.32% in year ending Mar 31, 2026 outperforming its 5 year avg. of 39.91%. (Source: Standalone Financials)

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
P&G Health	31.70	19.76	62.32	76.80	38.85	4.48	31.99	23.21	196.94	2.18	0.00	0.00
Abbott India	35.89	11.67	32.50	41.87	23.87	9.36	30.36	22.39	730.36	2.55	0.00	0.00
GSK Pharma	38.13	17.42	45.68	54.54	23.95	5.71	36.32	27.10	61.15	2.03	0.00	0.00
AstraZeneca	112.43	24.16	21.48	26.00	9.42	30.47	11.51	8.24	75.01	1.77	0.00	0.00
Pfizer	28.71	23.02	33.24	22.93	27.21	2.32	28.27	40.85	100.38	5.04	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Sanofi Consumer Healthcare India Ltd.
Sanofi India
Novartis India

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
P&G Health Stock Performance	-1.06	18.70	22.81	24.39	16.20	24.81	6.23
Abbott India Stock Performance	0.27	-4.74	3.27	-0.30	-16.61	25.44	63.47
GSK Pharma Stock Performance	2.91	-3.50	-3.93	-10.20	-21.86	80.71	59.49
AstraZeneca Stock Performance	-1.12	0.98	-0.22	-5.13	6.21	163.43	123.47
Pfizer Stock Performance	-0.13	-3.15	-5.87	-8.07	-8.94	18.54	-13.37
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	86,01,071	51.82 %	0.00
Pledge	0	0.00 %	0.00
FII	10,28,833	6.20 %	-0.77
DII	22,69,254	13.67 %	-0.16
MF	16,93,346	10.20 %	-0.28
Others	47,00,224	28.31 %	0.93

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	51.82	51.82	51.82	51.82
Pledge	0.00	0.00	0.00	0.00
FII	6.20	6.97	7.24	6.99
DII	13.67	13.84	13.90	14.15
Mutual Funds	10.20	10.48	10.56	10.65
Others	28.31	27.37	27.03	27.03

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Nippon India Small Cap Direct-G
Equity: Small Cap
4
- 420.69
  Amount Invested (in Cr.)
- 0.56%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI MNC Direct-G
Equity: Thematic-MNC
- 129.94
  Amount Invested (in Cr.)
- 4.84549895%
  % of AUM
- -6.53
  % Change (MoM basis)
DSP Healthcare Direct-G
Equity: Sectoral-Pharma
3
- 96.46
  Amount Invested (in Cr.)
- 2.92%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Final
450%
May 26, 2026
Board Meeting
Audited Results & Final Dividend
Mar 27, 2026
Special
500%
Feb 07, 2026

Board Meetings

Announced on	Meeting on
Mar 27, 2026	May 26, 2026
Audited Results & Final Dividend
Jan 21, 2026	Feb 06, 2026
Quarterly Results & Interim Dividend
Sep 29, 2025	Nov 05, 2025
Quarterly Results & Interim Dividend
Jun 27, 2025	Aug 01, 2025
Quarterly Results
Mar 26, 2025	May 29, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Feb 07, 2026 Feb 12, 2026 500%
Feb 06, 2026 Feb 12, 2026 1100%
May 29, 2025 Aug 22, 2025 450%
Jan 31, 2025 Feb 21, 2025 800%
May 26, 2026 - 450%
Bonus
Announced on Ex-Date
Sep 30, 1991 Nov 05, 1991
Bonus Ratio: 1 share(s) for every 2 shares held
Sep 11, 1986 -
Bonus Ratio: 3 share(s) for every 5 shares held
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
Feb 07, 2026	Feb 12, 2026	500%
Feb 06, 2026	Feb 12, 2026	1100%
May 29, 2025	Aug 22, 2025	450%
Jan 31, 2025	Feb 21, 2025	800%
May 26, 2026	-	450%

Announced on	Ex-Date
Sep 30, 1991	Nov 05, 1991
Bonus Ratio: 1 share(s) for every 2 shares held
Sep 11, 1986	-
Bonus Ratio: 3 share(s) for every 5 shares held

AGM/EGM Meetings

Announced on	Meeting on
Aug 06, 2025	Aug 29, 2025
-
Mar 10, 2025	Apr 11, 2025
-
Aug 22, 2024	Dec 05, 2024
Rs.60.0000 per share(600%)Final Dividend & A.G.M.
Aug 24, 2023	Nov 21, 2023
Rs.50.0000 per share(500%)Final Dividend & A.G.M.
Apr 10, 2023	May 12, 2023
-

About P&G Health

Procter & Gamble Health Ltd., incorporated in the year 1967, is a Mid Cap company (having a market cap of Rs 10,364.65 Crore) operating in Pharmaceuticals sector.

Procter & Gamble Health Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 374.45 Crore, down 1.00 % from last quarter Total Income of Rs 378.22 Crore and unchanged .00 % from last year same quarter Total Income of Rs Crore. Company has reported net profit after tax of Rs 94.60 Crore in latest quarter.

The company’s top management includes Mr.S Madhavan, Mr.Milind Thatte, Mr.Lokesh Chandak, Mr.Aalok Agrawal, Ms.Seema Sambasivan, Ms.Krishna Sarma, Mr.Sharad Tyagi, Ms.Zeal Rupani. Company has Haribhakti & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 1.66 Crore shares outstanding.

P&G Health Share Price Today is Rs. 6244.00. On previous day, the P&G Health Share Price (NSE) closed at Rs. 6249.5, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 51.82% of the stake in P&G Health shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of P&G Health stocks was 6.2% as compared to 6.97% in Dec 2025 with decrease of 0.77%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 13.67% as compared to 13.84% in Dec 2025 with decrease of 0.17%. Out of the total DII holdings in P&G Health shares 10.2% was held by mutual funds. The rest including public held is 28.31%. P&G Health stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
P&G Health Dividend: Ever since 1967, P&G Health dividends has been paid out around 47 times. As on 19 Jun, 2026, 03:40 PM IST, The overall dividend yield for P&G Health stands at 0.71%. The last dividend paid was on null (Rs. 45.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 196.94.

P&G Health Bonus: The most recent bonus issue had been in year November 5, 1991 around 34 years ago at 2 : 1 ratio. The first bonus issue was announced in Sep 1986.

Stock Forecast:
After showing 374.45 Cr. of sales and 1.0% of quarterly net loss, there have been multiple ups and downs in the P&G Health stock prices in the past few weeks. For example, P&G Health stock price on 11th of June 2026 was around Rs. 6207.0. P&G Health share price now stands at an average of Rs. 6244.00. Judging by last week's performance, stock is in up trend.

P&G Health has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for P&G Health share.

Historical Prices and Performance:
P&G Health, incorporated in 1967 is a Mid Cap company (with a market cap of Rs. 10475.04) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by P&G Health stock was 62.32%, 43.65%, 37.34%, 30.55% and 31.22% respectively.
The P&G Health share gave a 3 year return of 23.74% as compared to Nifty 50 which gave a return of 28.38%.
P&G Health announced 450.0% final dividend on null.

Key Metrics:
PE Ratio of P&G Health is 32.04
Prices/Sales Ratio of P&G Health is 5.66
Price/Book Ratio of P&G Health is 19.97

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For P&G Health, major competitors and peers include Abbott India, GSK Pharma, AstraZeneca and Pfizer. As of Dec 2025, the dividend yield of P&G Health stands at 0.71% while Abbott India, GSK Pharma, AstraZeneca and Pfizer stand at 2.51%, 2.52%, 0.0% and 1.65% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 32.04 and 19.97 respectively.

Leadership of P&G Health :
Zeal Rupani is Co. Secretary & Compl. Officer
S Madhavan is Chairman & Ind.Director
Milind Thatte is Managing Director
Lokesh Chandak is Executive Director & CFO
Seema Sambasivan is Non Executive Director
Aalok Agrawal is Non Executive Director
Krishna Sarma is Independent Director
Sharad Tyagi is Independent Director

Industry

Pharma - MNC

Key Indices Listed On

BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare, BSE AllCap, BSE NEXT 500

Address

P&G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),Mumbai, Maharashtra - 400009

Contact

investorgrievance.im@pg.com

https://www.pghealthindia.com

PE Ratio(x)	31.70
EPS - TTM(₹)	196.94
MCap(₹ Cr.)	10,364.65
MCap Rank	47
PB Ratio(x)	19.97
Div Yield(%)	0.72
Face Value(₹)	10.00
52W High(₹)	6,739.00
52W Low(₹)	4,707.00
MCap/Sales	5.66
Beta(1 Month)	0.56
BV/Share(₹)	316.01

PE Ratio(x)	32.04
EPS - TTM(₹)	196.94
MCap(₹ Cr.)	10,473.46
MCap Rank	47
PB Ratio(x)	20.02
Div Yield(%)	0.71
Face Value(₹)	10.00
52W High(₹)	6,701.40
52W Low(₹)	4,699.70
MCap/Sales	5.66
Beta(1 Month)	0.64
BV/Share(₹)	316.01

1 Day	-1.06%
1 Month	16.92%
3 Months	29.56%
1 Year	6.29%
3 Years	22.71%
5 Years	6.48%

1 Day	-0.11%
1 Month	18.01%
3 Months	30.86%
1 Year	7.82%
3 Years	24.24%
5 Years	7.72%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

P&G Health - Procter & Gamble Health Share Price

Key Metrics

P&G Health share price insights

P&G Health Share Price Returns

P&G Health Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Share Price Forecast

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Nippon India Small Cap Direct-G

UTI MNC Direct-G

DSP Healthcare Direct-G

P&G Health Top Searches

Corporate Actions

About P&G Health

Executive Leadership

Auditors

FAQs about P&G Health share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News